Discover

KVUE
Kenvue Inc.
19.20
1 x 19.05
1 x 19.21
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
19.20 +0.00 (0.00%)
Ytd11.30%
1y-8.83%
19.14
day range
19.31
14.11
52 week range
21.63
Open19.19Prev Close19.20Low19.14High19.31Mkt Cap36.86B
Vol8.02MAvg Vol20.53MEPS1.18P/E16.27Forward P/E15.53
Beta0.43Short Ratio3.41Inst. Own97.44%Dividend0.84Div Yield4.38
Ex Div Date08-12Earning08-0650-d Avg18.84200-d Avg17.701yr Est19.50
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-022026-090.28N/AN/AN/A
2026-08-062026-060.320.31-0.01-2.73%
2026-05-072026-030.260.320.0622.09%
2026-02-172025-120.220.270.0521.24%
2025-11-032025-090.260.280.027.61%
2025-08-072025-060.280.290.012.95%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-11UBSUpgradeNeutralNeutral
2026-07-21BarclaysUpgradeEqual-WeightEqual-Weight
2026-07-16UBSUpgradeNeutralNeutral
2026-04-15CitigroupUpgradeNeutralNeutral
2026-04-14BarclaysUpgradeEqual-WeightEqual-Weight
2026-04-07UBSUpgradeNeutralNeutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
DateNameRelationQuantityDescription
2026-03-09ALVARADO LUANIChief Operating Officer61.42KConversion of Exercise of derivative security
2026-03-09LAWSON CARLTONOfficer111.42KConversion of Exercise of derivative security
2025-03-04MEURER JANOfficer33.18KConversion of Exercise of derivative security
2025-03-04MONGON THIBAUTChief Executive Officer216.47KConversion of Exercise of derivative security
2025-12-14PERRY KIRK LChief Executive Officer62.55KConversion of Exercise of derivative security
2025-03-04RUH PAULChief Financial Officer56.20KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.150.83M2.89B7.85%
2026-03-30FMR, LLC135.09M2.59B7.03%
2026-03-30Vanguard Capital Management LLC124.42M2.39B6.48%
2026-06-29State Street Corporation121.62M2.33B6.33%
2026-03-30Vanguard Portfolio Management LLC92.46M1.77B4.81%
2026-03-30Pentwater Capital Management Lp52.00M997.88M2.71%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund60.84M1.17B3.17%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund48.69M934.35M2.53%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund41.39M794.35M2.16%
2026-06-29iShares Trust-iShares Core S&P 500 ETF26.49M508.42M1.38%
2026-06-29Fidelity Concord Street Trust-Fidelity 500 Index Fund24.63M472.66M1.28%
2026-06-29SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust23.21M445.32M1.21%
Dividend
DividendDate
0.212026-08-12
0.20752026-05-13
0.20752026-02-11
0.20752025-11-12
0.20752025-08-13
0.2052025-05-14